PDL1- IHC

Immunotherapy marker for Pembrolizumab. Please specify the immunotherapy drug being planned and the site of biopsy. Please send 1-2 representative H&E stained slides along with representative FFPE blocks.

TAT:
Specimen Type:
Immunohistochemistry Single Test

Description

Immunotherapy marker for Pembrolizumab. Please specify the immunotherapy drug being planned and the site of biopsy. Please send 1-2 representative H&E stained slides along with representative FFPE blocks.

Reviews

There are no reviews yet.

Be the first to review “PDL1- IHC”

Your email address will not be published. Required fields are marked *

Other Tests